Pavel Klener

26PUBLICATIONS
66CO-AUTHORS
Tumour immunologyPredictive and prognostic markersHaematological tumoursMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 23, 2026
Loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma.

|Sep 08, 2025
Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice.

Prokop Vodicka, Iva Hamova, Adriana Velasova

|Feb 18, 2025
Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors.

Lenka Daumova, Dmitry Manakov, Jiri Petrak

|Aug 19, 2024
Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies.

Nardjas Bettazova, Jana Senavova, Kristyna Kupcova

|May 07, 2024
Blockage of BCL-XL overcomes venetoclax resistance across BCL2+ lymphoid malignancies irrespective of BIM status.

Alexandra Dolnikova, Dmitry Kazantsev, Magdalena Klanova

|Aug 22, 2023
Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.

J Karolová, D Kazantsev, M Svatoň

Pageof 5

Frequent Collaborators

4 joint publications

Jana Karolova

4 joint publications

Karel Helman

3 joint publications

Ondrej Havranek

3 joint publications

Alexandra Dolnikova